<code id='1A38800988'></code><style id='1A38800988'></style>
    • <acronym id='1A38800988'></acronym>
      <center id='1A38800988'><center id='1A38800988'><tfoot id='1A38800988'></tfoot></center><abbr id='1A38800988'><dir id='1A38800988'><tfoot id='1A38800988'></tfoot><noframes id='1A38800988'>

    • <optgroup id='1A38800988'><strike id='1A38800988'><sup id='1A38800988'></sup></strike><code id='1A38800988'></code></optgroup>
        1. <b id='1A38800988'><label id='1A38800988'><select id='1A38800988'><dt id='1A38800988'><span id='1A38800988'></span></dt></select></label></b><u id='1A38800988'></u>
          <i id='1A38800988'><strike id='1A38800988'><tt id='1A38800988'><pre id='1A38800988'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:3

          Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

          advertisement

          For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          The biotech scorecard for Q1: 17 stock
          The biotech scorecard for Q1: 17 stock

          RyanPierse/GettyImagesHereisSTAT’sbiotechscorecard,ourregularledgerofstock-movingbiotechevents,forth

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          The boys, now 6, who are gene therapy’s ‘edge case’ problem

          HiramSecrist(left),whohasDuchennemusculardystrophy,withhismother,KristenSecrist(center),andhisgrandm